Onconetix, Inc. Treasury Stock, Common, Value
Onconetix, Inc. (ONCO) had Treasury Stock, Common, Value of $625.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Treasury Stock, Value
us-gaap:TreasuryStockCommonValue · last filed 2026-08-13
- 2026-06-30: Treasury Stock, Common, Value $625.79K.
- 2026-03-31: Treasury Stock, Common, Value $625.79K.
- 2025-12-31: Treasury Stock, Common, Value $625.79K.
- 2025-09-30: Treasury Stock, Common, Value $625.79K.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $625.79K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $625.79K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $625.79K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $625.79K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $625.79K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $625.79K 10-Q · filed 2025-06-12 |
| 2024-12-31 | $625.79K 10-K · filed 2026-03-13 |
| 2024-09-30 | $625.79K 10-Q · filed 2024-12-10 |
| 2023-12-31 | $625.79K 10-Q · filed 2024-12-10 |
| 2023-03-31 | $33.50K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $600.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |